Zheng Xing Xing Ye Ri Bao·2025-11-17 08:49Market Overview - The Chinese traditional medicine sector experienced a decline of 1.47% on November 17, with Wanbangde leading the drop [1] - The Shanghai Composite Index closed at 3972.03, down 0.46%, while the Shenzhen Component Index closed at 13202.0, down 0.11% [1] Stock Performance - Notable gainers included: - Jiaying Pharmaceutical (002198) with a closing price of 8.43, up 10.05% and a trading volume of 390,200 shares [1] - Weikang Pharmaceutical (300878) closed at 29.62, up 6.85% with a trading volume of 97,100 shares [1] - Significant losers included: - Wanbangde (002082) closed at 13.61, down 6.91% with a trading volume of 186,000 shares [2] - Teyi Pharmaceutical (002728) closed at 14.17, down 6.84% with a trading volume of 1,277,300 shares [2] Capital Flow - The traditional medicine sector saw a net outflow of 1.639 billion yuan from institutional investors, while retail investors contributed a net inflow of 1.444 billion yuan [2][3] - The main stocks with significant capital inflow included: - Jiaying Pharmaceutical with a net inflow of 62.818 million yuan, accounting for 19.12% of its trading volume [3] - Huasheng Technology (000790) with a net inflow of 20.121 million yuan, representing 11.37% of its trading volume [3]